Commentary
Clinical Pharmacology & Therapeutics (2007) 82, 373–376. doi:10.1038/sj.clpt.6100350
Translation of Pharmacogenetics into Clinically Relevant Testing Modalities
L M Baudhuin1, L J Langman1 and D J O'Kane1
1Department of Laboratory Medicine and Pathology, Nucleotide Polymorphism Laboratory, Mayo Clinic, Rochester, Minnesota, USA
Correspondence: DJ O'Kane, (okane.dennis@mayo.edu)
